200 related articles for article (PubMed ID: 25712051)
1. Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions.
Han BB; Li S; Tong M; Holpuch AS; Spinney R; Wang D; Border MB; Liu Z; Sarode S; Pei P; Schwendeman SP; Mallery SR
Cancer Prev Res (Phila); 2015 May; 8(5):419-30. PubMed ID: 25712051
[TBL] [Abstract][Full Text] [Related]
2. Fenretinide combines perturbation of signaling kinases, cell-extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells.
Wang D; Pei P; Shea FF; Bissonnette C; Nieto K; Din C; Liu Y; Schwendeman SP; Lin YX; Spinney R; Mallery SR
Carcinogenesis; 2022 Oct; 43(9):851-864. PubMed ID: 35974187
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of focal adhesion kinase regulation.
Cohen LA; Guan JL
Curr Cancer Drug Targets; 2005 Dec; 5(8):629-43. PubMed ID: 16375667
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine 397 phosphorylation is critical for FAK-promoted Rac1 activation and invasive properties in oral squamous cell carcinoma cells.
Chiu YW; Liou LY; Chen PT; Huang CM; Luo FJ; Hsu YK; Yuan TC
Lab Invest; 2016 Mar; 96(3):296-306. PubMed ID: 26752742
[TBL] [Abstract][Full Text] [Related]
5. Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.
Mallery SR; Wang D; Santiago B; Pei P; Schwendeman SP; Nieto K; Spinney R; Tong M; Koutras G; Han B; Holpuch A; Lang J
Cancer Prev Res (Phila); 2017 Jan; 10(1):76-88. PubMed ID: 27756753
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
[TBL] [Abstract][Full Text] [Related]
7. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with premalignant oral epithelial lesions.
de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
Oral Oncol; 2012 Jul; 48(7):641-6. PubMed ID: 22377015
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation.
Crowe DL; Ohannessian A
BMC Cancer; 2004 May; 4():18. PubMed ID: 15132756
[TBL] [Abstract][Full Text] [Related]
9. The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion.
Kamarajan P; Garcia-Pardo A; D'Silva NJ; Kapila YL
BMC Cancer; 2010 Jun; 10():330. PubMed ID: 20579373
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma.
Hwang YS; Park KK; Chung WY
Eur J Pharmacol; 2013 Sep; 715(1-3):286-95. PubMed ID: 23707351
[TBL] [Abstract][Full Text] [Related]
11. SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling.
Westhoff MA; Serrels B; Fincham VJ; Frame MC; Carragher NO
Mol Cell Biol; 2004 Sep; 24(18):8113-33. PubMed ID: 15340073
[TBL] [Abstract][Full Text] [Related]
12. FAK displacement from focal adhesions: a promising strategy to target processes implicated in cancer progression and metastasis.
Antoniades I; Kyriakou M; Charalambous A; Kalalidou K; Christodoulou A; Christoforou M; Skourides PA
Cell Commun Signal; 2021 Jan; 19(1):3. PubMed ID: 33413438
[TBL] [Abstract][Full Text] [Related]
13. Targeting Pyk2 to beta 1-integrin-containing focal contacts rescues fibronectin-stimulated signaling and haptotactic motility defects of focal adhesion kinase-null cells.
Klingbeil CK; Hauck CR; Hsia DA; Jones KC; Reider SR; Schlaepfer DD
J Cell Biol; 2001 Jan; 152(1):97-110. PubMed ID: 11149924
[TBL] [Abstract][Full Text] [Related]
14. p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling.
Srivastava K; Pickard A; McDade S; McCance DJ
Oncotarget; 2017 Mar; 8(10):16202-16219. PubMed ID: 26001294
[TBL] [Abstract][Full Text] [Related]
15. FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation.
Wu X; Gan B; Yoo Y; Guan JL
Dev Cell; 2005 Aug; 9(2):185-96. PubMed ID: 16054026
[TBL] [Abstract][Full Text] [Related]
16. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase activity is required for actomyosin contractility-based invasion of cells into dense 3D matrices.
Mierke CT; Fischer T; Puder S; Kunschmann T; Soetje B; Ziegler WH
Sci Rep; 2017 Feb; 7():42780. PubMed ID: 28202937
[TBL] [Abstract][Full Text] [Related]
18. Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention.
Mallery SR; Wang D; Santiago B; Pei P; Bissonnette C; Jayawardena JA; Schwendeman SP; Spinney R; Lang J
Mol Cancer Ther; 2019 Dec; 18(12):2308-2320. PubMed ID: 31515297
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of fenretinide on cell-matrix interactions.
Vaccari M; Silingardi P; Argnani A; Horn W; Giungi M; Mascolo MG; Grilli S; Colacci A
Anticancer Res; 2000; 20(5A):3059-66. PubMed ID: 11062723
[TBL] [Abstract][Full Text] [Related]
20. Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells.
Golubkov V; Garcia A; Markland FS
Anticancer Res; 2005; 25(1A):249-53. PubMed ID: 15816545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
